
|Articles|April 1, 2002
Lengthy remission rates uphold alefacept quality of life benefits
Maui, Hawaii - Alefacept (Amevive) for treating patients with chronic plaque psoriasis provides clinical benefits that may be long-term and are associated with significant improvement in quality of life, Mark Lebwohl, M.D., said at the 26th annual Hawaii Dermatology Seminar.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
3
Top 5 Articles of the Week: December 7-12
4
Dermatology Times Spot Test: December 14, 2025
5


















